Significant cost savings and optimized workflow efficiencies with one vendor consolidation.

Introduction

Pathology laboratories in the United States are facing dramatic changes. Balancing the demands for personalized medicine with the quality and economic requirements implemented as part of the Affordable Care Act is a tough challenge even for the most efficient labs. Labs need new solutions to achieve the requirements of greater accountability, quality and efficiencies while lowering costs. Labs are also looking for solutions that will meet the high quality preparation, staining and image analysis of tissue specimens required for many of today’s biomarker tests related to personalized medicine. All of these changes must be addressed in the face of shifting from a fee-forservice structure to a value-based reimbursement model.

Pathology, Inc. is an independent laboratory in Southern California with subspecialties in anatomic and molecular pathology. It has experienced rapid growth over the past few years, but with industrywide cuts in reimbursement, the lab has sought solutions to help maximize its workflow, reduce labor and reagent costs, and still maintain the high quality its clients know and trust.